Thoracic Oncology
Clinical research in non-small cell lung cancer focuses on patients with completely resected stage IB, stage II, and stage IIIA disease, with attention to PD-L1-expressing and EGFR/ALK-negative tumours.
- Adjuvant immunotherapy
- Disease-free survival
- Resected lung cancer
The oncology portfolio is centred on post-surgical treatment strategies aimed at reducing recurrence risk in resected lung malignancy.
Burn Care and Critical Injury
Research activity also includes patients with severe thermal injury, addressing the complications of major burn trauma and the management of life-threatening burn injury in the acute care setting.
- Persistent organ dysfunction
- All-cause mortality
- Acute burn management
This area reflects interest in outcomes that are central to intensive treatment and recovery after extensive burns.
Supportive and Adjunctive Therapy
The funded studies include interventions used alongside established care pathways, with emphasis on adjuvant treatment in oncology and supportive therapy in critical injury.
- Standard of care
- Placebo-controlled treatment evaluation
- Recovery-focused care
These topics show interest in therapies intended to complement existing treatment approaches in both cancer and critical care.
Multicentre Clinical Research
The sponsor supports studies conducted across a wide network of collaborating sites in Canada and other participating countries, enabling research in both oncology and acute injury medicine.
- Collaborative site networks
- International trial participation
- Clinical outcomes research
This work spans geographically distributed patient populations with distinct therapeutic needs.
